Edition:
United Kingdom

People: BTG PLC (BTG.L)

BTG.L on London Stock Exchange

835.00GBp
4:37pm BST
Change (% chg)

0.00 (+0.00%)
Prev Close
835.00
Open
836.00
Day's High
836.00
Day's Low
834.50
Volume
601,468
Avg. Vol
1,125,927
52-wk High
853.00
52-wk Low
467.40

Foden, Susan 

Dr. Susan Elizabeth Foden, Ph.D., serves as Independent Non-Executive Director of the Company. Susan appointed to the Board in March 2015. She is a member of the Remuneration Committee. Susan currently holds non-executive roles with BerGenBio ASA, Evgen Pharma plc and Vectura Group plc, and is an advisory board member for CD3 (a joint initiative between Leuven University and the European Investment Fund). Susan brings extensive industry experience to the BTG Board with a strong track record of having assisted in the development of a number of businesses in the sector. She was Investor Director with the venture capital firm Merlin Biosciences, was formerly CEO of the technology transfer company, Cancer Research Campaign Technology Ltd and was Head of Academic Liaison at Celltech Ltd.

Basic Compensation

Total Annual Compensation, GBP 54,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 3,000
Fiscal Year Total, GBP 57,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --